These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34670568)

  • 1. Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
    Cooley LS; Rudewicz J; Souleyreau W; Emanuelli A; Alvarez-Arenas A; Clarke K; Falciani F; Dufies M; Lambrechts D; Modave E; Chalopin-Fillot D; Pineau R; Ambrosetti D; Bernhard JC; Ravaud A; Négrier S; Ferrero JM; Pagès G; Benzekry S; Nikolski M; Bikfalvi A
    Mol Cancer; 2021 Oct; 20(1):136. PubMed ID: 34670568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma.
    Song Q; Zheng Y; Wu J; Wang S; Meng L; Yao Q; Li Z; Lian S
    Front Immunol; 2021; 12():717688. PubMed ID: 34630392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.
    Mao W; Wang K; Xu B; Zhang H; Sun S; Hu Q; Zhang L; Liu C; Chen S; Wu J; Chen M; Li W; Peng B
    Mol Cancer; 2021 Nov; 20(1):142. PubMed ID: 34740354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
    Zeng Q; Zhang W; Li X; Lai J; Li Z
    Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma.
    Wang R; Zheng J; Shao X; Ishii Y; Roy A; Bello A; Lee R; Zhang J; Wind-Rotolo M; Feng Y
    J Immunother Cancer; 2019 Dec; 7(1):348. PubMed ID: 31829287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
    Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
    Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
    White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
    Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.
    Lee JC; Yotis DM; Lee JY; Sarabusky MA; Shrum B; Champagne A; Ismail OZ; Tutunea-Fatan E; Leong HS; Gunaratnam L
    Sci Rep; 2021 Jun; 11(1):11840. PubMed ID: 34088927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
    Wang C; Li Y; Chu CM; Zhang XM; Ma J; Huang H; Wang YN; Hong TY; Zhang J; Pan XW; Zheng JC; Jiang N; Hu CY; Ma X; Sun YH; Cui XG
    EBioMedicine; 2019 Jan; 39():255-264. PubMed ID: 30558998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
    Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
    Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
    Kubota S; Yoshida T; Kageyama S; Isono T; Yuasa T; Yonese J; Kushima R; Kawauchi A; Chano T
    World J Surg Oncol; 2020 Oct; 18(1):270. PubMed ID: 33092599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer.
    Cheng Y; Xu T; Li S; Ruan H
    Aging (Albany NY); 2019 Dec; 11(24):12165-12176. PubMed ID: 31844035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies.
    Xiao Y; Meierhofer D
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease.
    Campbell L; Al-Jayyoussi G; Gutteridge R; Gumbleton N; Griffiths R; Gumbleton S; Smith MW; Griffiths DF; Gumbleton M
    J Transl Med; 2013 Oct; 11():255. PubMed ID: 24119769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The m
    Gong D; Zhang J; Chen Y; Xu Y; Ma J; Hu G; Huang Y; Zheng J; Zhai W; Xue W
    J Exp Clin Cancer Res; 2019 Jun; 38(1):233. PubMed ID: 31159832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.